Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medius Holdings CoTSE:3154 -0.74%62 EBITDA Margin % is 1.80% as of Mar. 2026, which is 20% above its 10-year median of 1.50. GuruFocus rates TSE:3154 with a GF Score™ of 62/100 and a GF Value™ of 円979.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Medius Holdings Co ranks worse than 60.81% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medius Holdings Co's EBITDA for the
three
months ended in Mar. 2026 was 円1,409 Mil. Medius Holdings Co's Revenue for the
three
months ended in Mar. 2026 was 円78,469 Mil. Therefore, Medius Holdings Co's EBITDA margin for the quarter that ended in Mar. 2026 was 1.80%.
Medius Holdings Co (TSE:3154) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medius Holdings Co EBITDA Margin % Related Terms
Medius Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Medius Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3154 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Medius Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medius Holdings Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medius Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medius Holdings Co (TSE:3154) has a EBITDA Margin % of 1.80% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medius Holdings Co and its competitors. This is 20% above median its historical median of 1.50. Over the past decade, Medius Holdings Co's EBITDA Margin % has ranged from 0.64 to 1.99. According to the industry distribution chart, Medius Holdings Co ranks #495 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 60.8%.
Is Medius Holdings Co's EBITDA Margin % too high?
Medius Holdings Co's current EBITDA Margin % of 1.80% is 20% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 1.99. The Medical Devices & Instruments industry median EBITDA Margin % is 7.74. Medius Holdings Co's value of 1.80% is 76.7% below this industry median. Based on the distribution chart, Medius Holdings Co ranks #495 out of 814 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medius Holdings Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medius Holdings Co ranks #495 out of 814 companies for EBITDA Margin %. This places Medius Holdings Co in the lower half of its industry. The industry median EBITDA Margin % is 7.74. Medius Holdings Co's value of 1.80% is 76.7% below this benchmark. Historically, Medius Holdings Co's own EBITDA Margin % has ranged from 0.64 to 1.99 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 7.74, Medius Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.74, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medius Holdings Co's current EBITDA Margin % of 1.80% is 76.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medius Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medius Holdings Co's current EBITDA Margin % is 1.80%, which is 20% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Modestly Undervalued. The stock's GF Value™ is 円979.45, compared to a current price of 円809.00 — trading 17.4% below its estimated fair value. The current EBITDA Margin % is 1.80%, which is 20% above median its 10-year median of 1.50 and 76.7% below the Medical Devices & Instruments industry median of 7.74. Medius Holdings Co's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current EBITDA Margin % is 1.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medius Holdings Co (TSE:3154) Overvalued in 2026?
Based on GuruFocus' analysis, Medius Holdings Co stock appears to be undervalued.
The current stock price of 円809.00 is trading 17.4% below its estimated GF Value™ of 円979.45.
GuruFocus considers Medius Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3154:
EBITDA Margin %: 1.80% (20% above median its 10-year median of 1.50)
GF Value™: 円979.45 vs. price of 円809.00 (17.4% below fair value)
Industry Position: 76.7% below the Medical Devices & Instruments median (#495 of 814)
No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
62GF Score
Get the complete analysis for TSE:3154
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3154 has been successfully added to your 
